Improved Benefit of SPECT/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors

Abstract

Objective: To assess the clinical utility of SPECT/ CT in subjects with endocrine and neuroendocrine tumors compared to SPECT alone.Material and Methods: 48 subjects (31 women;17 men; mean age 54±11) with clinical suspicion or diagnosis of endocrine and neuroendocrine tumor had 50 SPECT/CT scans (32 Tc-99m MIBI, 5 post treatment I-131, 8 In-111 Pentetreotide, and 5 I-123 MIBG). SPECT alone findings were compared to SPECT/CT and to pathology or radiological follow up.Results: From the 32 Tc-99m MIBI scans, SPECT accurately localized the lesion in 22 positive subjects while SPECT/CT did in 31 subjects. Parathyroid lesions not seen on SPECT alone were smaller than 10 mm. In five post treatment I-131 scans, SPECT alone neither characterized, nor localized any lesions accurately. SPECT/CT revealed 3 benign etiologies, a metastatic lymph node, and one equivocal lesion. In 8 In-111 Pentetreotide scans, SPECT alone could not localize primary or metastatic lesions in 6 subjects all of which were localized with SPECT/CT. In five I-123 MIBG scans, SPECT alone could not detect a 1.1 cm adrenal lesion or correctly characterize normal physiologic adrenal uptake in consecutive scans of the same patient with prior history of adrenelectomy, all of which were correctly localized and characterized with SPECT/CT.Conclusion: SPECT/CT is superior to SPECT alone in the assessment of endocrine and neuroendocrine tumors. It is better in lesion localization and lesion characterization leading to a decrease in the number of equivocal findings. SPECT/CT should be included in the clinical work up of all patients with diagnosis or suspicion of endocrine and neuroendocrine tumors.Conflict of interest:None declared.

Comparison of planar imaging with I-123 MIBG scintigraphy and SPECT-CT imaging for pheochromocytoma

“…(13) tarafından endokrin ve nöroendok-rin tümör tanısı veya şüphesi olan 48 hastanın dahil edildiği çalışmada SPECT-BT'nin SPECT görün-tülemeye karşı üstünlüğünü değerlendirilmiştir. Derlin ve ark.…”

SPECT/CT in neuroendocrine tumours

“…Finally, the improved benefit of SPECT/CT compared to SPECT alone for the accurate localisation of NETs was recently confirmed in a study including five I-123 MIBG scans and eight SRS studies [49]. Pathology and radiological follow-up served as the reference standard.…”

Extra-adrenal pheochromocytoma at the organ of Zuckerkandl: a case report and literature review

“…Although, SPECT/CT is superior to SPECT in terms of diagnostic accuracy and localization of neuroendocrine tumors, that technology is not available at this institution [1]. Thus, through SPECT, the patient was diagnosed with an extra-adrenal PGL.…”